Herding: a new phenomenon affecting medical decision-making in multiple sclerosis care? Lessons learned from DIScUTIR MS

被引:11
|
作者
Saposnik, Gustavo [1 ,2 ,3 ]
Maurino, Jorge [4 ]
Sempere, Angel P. [5 ]
Ruff, Christian C. [2 ]
Tobler, Philippe N. [2 ]
机构
[1] Univ Toronto, St Michaels Hosp, Dept Med, Div Neurol, 55 Queen St East, Toronto, ON M5C 1R6, Canada
[2] Univ Zurich, Dept Econ, Lab Social & Neural Syst Res, Zurich, Switzerland
[3] Univ Toronto, Li Ka Shing Knowledge Inst, St Michaels Hosp, Toronto, ON, Canada
[4] Roche Farma, Dept Med, Neurosci Area, Madrid, Spain
[5] Hosp Gen Univ Alicante, Dept Neurol, Alicante, Spain
来源
PATIENT PREFERENCE AND ADHERENCE | 2017年 / 11卷
基金
瑞士国家科学基金会;
关键词
multiple sclerosis; herding; disease-modifying therapy; neuroeconomics; decision-making; risk aversion; SOCIAL-INFLUENCE; INTERFERON-BETA; MANAGEMENT; RISK; MRI;
D O I
10.2147/PPA.S124192
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Herding is a phenomenon by which individuals follow the behavior of others rather than deciding independently on the basis of their own private information. A herding-like phenomenon can occur in multiple sclerosis (MS) when a neurologist follows a therapeutic recommendation by a colleague even though it is not supported by best practice clinical guidelines. Limited information is currently available on the role of herding in medical care. The objective of this study was to determine the prevalence (and its associated factors) of herding in the management of MS. Methods: We conducted a study among neurologists with expertise in MS care throughout Spain. Participants answered questions regarding the management of 20 case scenarios commonly encountered in clinical practice and completed 3 surveys and 4 experimental paradigms based on behavioral economics. The herding experiment consisted of a case scenario of a 40-year-old woman who has been stable for 3 years on subcutaneous interferon and developed a self-limited neurological event. There were no new magnetic resonance imaging (MRI) lesions. Her neurological examination and disability scores were unchanged. She was advised by an MS neurologist to switch from interferon to fingolimod against best practice guidelines. Multivariable logistic regression analysis was conducted to evaluate factors associated with herding. Results: Out of 161 neurologists who were invited to participate, 96 completed the study (response rate: 60%). Herding was present in 75 (78.1%), having a similar prevalence in MS experts and general neurologists (68.8% vs 82.8%; P=0.12). In multivariate analyses, the number of MS patients seen per week was positively associated with herding (odds ratio [OR] 1.08, 95% CI 1.01-1.14). Conversely, physician's age, gender, years of practice, setting of practice, or risk preferences were not associated with herding. Conclusion: Herding was a common phenomenon affecting nearly 8 out of 10 neurologists caring for MS patients. Herding may affect medical decisions and lead to poorer outcomes in the management of MS.
引用
收藏
页码:175 / 180
页数:6
相关论文
共 19 条
  • [1] Decision-making in Multiple Sclerosis: The Role of Aversion to Ambiguity for Therapeutic Inertia among Neurologists (DIScUTIR MS)
    Saposnik, Gustavo
    Sempere, Angel P.
    Prefasi, Daniel
    Selchen, Daniel
    Ruff, Christian C.
    Maurino, Jorge
    Tobler, Philippe N.
    FRONTIERS IN NEUROLOGY, 2017, 8
  • [2] Decision making under uncertainty, therapeutic inertia, and physicians' risk preferences in the management of multiple sclerosis (DIScUTIR MS)
    Saposnik, Gustavo
    Sempere, Angel Perez
    Raptis, Roula
    Prefasi, Daniel
    Selchen, Daniel
    Maurino, Jorge
    BMC NEUROLOGY, 2016, 16
  • [3] Participation in medical decision-making: Attitudes of Italians with multiple sclerosis
    Giordano, Andrea
    Mattarozzi, Katia
    Pucci, Eugenio
    Leone, Maurizio
    Casini, Federica
    Collimedaglia, Laura
    Solari, Alessandra
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2008, 275 (1-2) : 86 - 91
  • [4] Decision making under uncertainty, therapeutic inertia, and physicians’ risk preferences in the management of multiple sclerosis (DIScUTIR MS)
    Gustavo Saposnik
    Angel Perez Sempere
    Roula Raptis
    Daniel Prefasi
    Daniel Selchen
    Jorge Maurino
    BMC Neurology, 16
  • [5] Implementing Shared Decision-Making for Multiple Sclerosis: The MS-SUPPORT Tool
    Col, Nananda F.
    Solomon, Andrew J.
    Alvarez, Enrique
    Pbert, Lori
    Ionete, Carolina
    BerriosMorales, Idanis
    Chester, Jennifer
    Kutz, Christen
    Iwuchukwu, Crystal
    Livingston, Terrie
    Springmann, Vicky
    Col, Hannah, V
    Ngo, Long H.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 80
  • [6] Lessons learned by (from?) an economist working in medical decision making
    Wakker, Peter P.
    MEDICAL DECISION MAKING, 2008, 28 (05) : 690 - 698
  • [7] Decision-making in localized prostate cancer: lessons learned from an online support group
    Huber, Johannes
    Ihrig, Andreas
    Peters, Tim
    Huber, Christian G.
    Kessler, Anja
    Hadaschik, Boris
    Pahernik, Sascha
    Hohenfellner, Markus
    BJU INTERNATIONAL, 2011, 107 (10) : 1570 - 1575
  • [8] Influence of Meta-Information on Decision-Making: Lessons Learned from Four Case Studies
    Riveiro, Maria
    Hdildin, Tow
    Falkman, Goran
    2014 IEEE INTERNATIONAL INTER-DISCIPLINARY CONFERENCE ON COGNITIVE METHODS IN SITUATION AWARENESS AND DECISION SUPPORT (COGSIMA), 2014, : 14 - 20
  • [9] Innovative Medical Technology and the Treatment Decision-Making Process in Multiple Sclerosis: A Focus Group Study to Examine Patient Perspectives
    Visser, L. A.
    De Mul, M.
    Redekop, W. K.
    PATIENT PREFERENCE AND ADHERENCE, 2021, 15 : 927 - 937
  • [10] Decision-Making in the Era of New Medical Technologies in Pediatric Hematology-Oncology: The Death of Palliative Care?
    Fortin, Sylvie
    Le Gall, Josiane
    Richer, Johanne
    Payot, Antoine
    Duval, Michel
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2021, 43 (07) : 271 - 276